InCarda Therapeutics

About:

Incarda Therapeutics offers a novel approach to treat cardiovascular conditions and diseases by the inhalation route.

Website: http://incardatherapeutics.com

Top Investors: Deerfield, Sofinnova Partners, Innoviva, Asset Management Ventures (AMV), Morningside Venture Investments

Description:

InCarda Therapeutics is a clinical-stage drug delivery company pioneering a novel approach of treating acute cardiovascular diseases/conditions by the inhalation route. Lead product is InRhythm, an inhaled formulation of an antiarrhythmic drug to treat acute paroxysmal atrial fibrillation events within minutes at home, at work, or anywhere. Completed Phase 1 and currently advancing lead product through Phase 2. InCarda Therapeutics was founded in Newark, California.